Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches
Explore this paper's citation graph
Summary
This review will critically appraise the evidence base underpinning the main treatment approaches in operable oesophagogastric adenocarcinoma, highlighting variations in treatment by factors such as geographical area and primary tumor site.
- Type
- review
- Published
- 2018-02-12
- Cited by
- 6
- References
- 79
- OpenAlex
- https://openalex.org/W2790677311
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:26095371
Keywords
Medicine, Adenocarcinoma, Radiation therapy, Oncology, Adjuvant
References
- Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.
- Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
- Food intake and nutritional status after total gastrectomy: results of a nutritional follow-up.
- Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol
- Post-surgical chemotherapy versus surgery alone for resectable gastric cancer.
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
- Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: A meta‐analysis of randomized controlled trials
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
- Current and Future Therapies for Advanced Gastric Cancer.
- Single-Institution Retrospective Comparison of Preoperative Versus Definitive Chemoradiotherapy for Adenocarcinoma of the Esophagus
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
- Comparisons of Gastric Cancer Treatments: East vs. West
- Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review
- Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma
- Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.
- Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.
- Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis
- Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.
Cited by
- Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer
- Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction
- Anlotinib combined with SOX regimen (S1 (tegafur, gimeracil and oteracil porassium capsules) + oxaliplatin) in treating stage IV gastric cancer: study protocol for a single-armed and single-centred clinical trial
- Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis
- Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
- The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection
Related papers
- Research progress of aluminum adjuvant
- Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine
- Immune Adjuvant Effect of CFNCpG Motif on Antigen of Inactivated BVDV1
- Adjuvant formulations for experimental vaccines.
- Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant
- Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
- Changing Trends in Gastric Carcinoma at a University Medical Center: A Twelve-year Retrospective Analysis
- Gastric adenocarcinoma with choriocarcinomatous and hepatoid differentiation